Dollar General Instant Coffee Recall Issued Due to Glass Fragments in Clover Valley Jars

Dollar General Instant Coffee Recall Issued Due to Glass Fragments in Clover Valley Jars

Dollar General has recalled certain jars of Clover Valley Instant Coffee after a customer discovered pieces of glass inside the product.

The U.S. Food and Drug Administration (FDA) announced the Clover Valley Instant Coffee recall on August 12, stating that jars of coffee potentially contaminated with glass fragments had been distributed to Dollar General stores in every U.S. state except for Alaska and Hawaii.

Clover Valley Instant Coffee is a private label sold exclusively through Dollar General. According to the company, the issue was brought to their attention after a customer reported finding foreign material inside one of the jars.

Swallowing glass can result in serious health complications, including dental injuries, cuts to the mouth or throat, and potentially life-threatening internal damage if the fragments travel through the digestive tract.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

The products impacted by this recall include 8-ounce jars of Clover Valley Instant Coffee sold between July 9 and July 21. They can be identified by UPC 876941004069, and the following lot numbers:

  • Lot: L-5163, Best By 12/13/2026
  • Lot: L-5164, Best by 12/13/2026
  • Lot: L-5165, Best by 12/14/2026

The recalled coffee may have been sold in all 48 continental U.S. states, excluding Alaska and Hawaii, where Dollar General does not operate. No injuries have been reported to date.

Consumers are urged to discard any affected jars and contact Dollar General for a full refund, including applicable taxes. The company has launched an investigation to determine the source of the contamination.

The customer service team for Dollar General can be reached via email at customercare@dollargeneral.com or by phone at 1-888-309-9030 from 6 a.m. to 1 a.m. CST seven days a week. Additional information can also be requested from the company’s Media Relations Department at dgpr@dg.com.

Sign up for more recall and legal news that could affect you or your family.

Written By: Michael Adams

Senior Editor & Journalist

Michael Adams is a senior editor and legal journalist at AboutLawsuits.com with over 20 years of experience covering financial, legal, and consumer protection issues. He previously held editorial leadership roles at Forbes Advisor and contributes original reporting on class actions, cybersecurity litigation, and emerging lawsuits impacting consumers.



0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

An increasing number of Ozempic and Mounjaro users are reporting sudden, irreversible vision loss from NAION side effects, prompting new lawsuits and a federal push to consolidate blindness claims into a dedicated multidistrict litigation.
Cartiva is urging federal judges to reject consolidation of toe-implant lawsuits, arguing that an MDL would interfere with individual claim resolutions that the company says are already being handled efficiently outside of court.
The first Covidien Symbotex mesh bellwether has been restored to the 2026 trial calendar, signaling renewed momentum in a litigation where more than 2,000 similar claims are still awaiting resolution.